The digestive enzymes market is projected to grow at a CAGR of 7.22% to reach US$1501.206 million in 2024 from US$988.176 million in 2018. Digestive enzymes are the complex proteins involved in breaking down complex macromolecules into their constituents for easy absorption and utilization by the body. Digestive enzymes need specific pH and temperature to work optimally. It is essential to maintain a healthy balance of digestive enzymes to optimize healthy digestion. Several digestive enzymes are commercially available as supplements and for the management of digestive disorders. They are effective at relieving common issues, including occasional gas, bloating, indigestion, heartburn, and general discomfort. The market is digestive enzymes is estimated to show significant growth during the given forecast period owing to the rising prevalence of the gastrointestinal and abdominal disorders. The shift from the healthy eating habits will also propel the growth of digestive enzymes market. Rising awareness among people regarding preventive health management will also have a significant positive on the growth of the market. However, the availability of alternatives such as probiotics and prebiotics will hamper the growth of the market.
Rising prevalence of the gastrointestinal and abdominal disorders
Growing geriatric population
Availability of alternatives
In July 2019, USANA earns seal of approval for digestive enzyme supplement, which can help and relieve occasional stomach discomfort and supports digestive systems after big meals.
The major players profiled in the Digestive Enzymes market include Enzymedica, Deerland Enzymes, Inc., AST Enzymes, Onnit Labs, Inc, Metagenics, National Enzyme Company Inc., Garden of Life Inc., Amway Corporation, and Country Life, LLC.
The Digestive Enzymes market has been analyzed through the following segments:
Middle East and Africa